We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current BOLD market cap is 59.32M. The company's latest EPS is USD -2.2168 and P/E is -1.20.
Quarter End | Mar 2024 | Jun 2024 |
---|---|---|
USD (US$) | ||
Total Revenue | 0 | 0 |
Operating Income | -16.88M | -19.39M |
Net Income | -15.43M | -16.98M |
Year End 31 December 2023 | 2023 |
---|---|
USD (US$) | |
Total Revenue | 0 |
Operating Income | -54.8M |
Net Income | -49.43M |
Quarter End | Mar 2024 | Jun 2024 |
---|---|---|
USD (US$) | ||
Total Assets | 117.08M | 188.2M |
Total Liabilities | 10.64M | 8.96M |
Total Equity | -141.18M | 179.25M |
Year End 31 December 2023 | 2023 |
---|---|
USD (US$) | |
Total Assets | 129.89M |
Total Liabilities | 9.36M |
Total Equity | -127.08M |
Market Cap | 59.32M |
Price to Earnings Ratio | -1.20 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 2.5 |
Price to Book Ratio | 0.49 |
Dividend Yield | - |
Shares Outstanding | 22.3M |
Average Volume (1 week) | 155.86k |
Average Volume (1 Month) | 97.22k |
52 Week Change | -95.56% |
52 Week High | 59.97 |
52 Week Low | 2.33 |
Spread (Intraday) | 0.07 (2.61%) |
Company Name | Boundless Bio Inc |
Address |
corporation trust center wilmington, delaware 19801 |
Website | https://www.boundlessbio.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions